Cardiopulmonary bypass pumps and thrombin generation: What goes around comes around

ASAIO Journal

Volumn 44, Issue 6, 1998, Pages 794-798

  Brister, Stephanie J ^a   Pelletier, Angela ^a   Fedorshyn, John ^a   Puchalski, Steven ^a   Buchanan, Michael R ^b,c  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CENTRIFUGAL PUMPS; COAGULATION; ENZYMES; FILTERS (FOR FLUIDS); HYPOTHERMIA;

CARDIOPULMONARY BYPASS; FIBRIN; HYPERCOAGULATION; THROMBIN;

CARDIOVASCULAR SURGERY;

THROMBIN;

ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FIBRIN DEPOSITION; HEPARINIZATION; HYPERCOAGULABILITY; HYPOTHERMIA; NONHUMAN; SPECTROPHOTOMETRY; SWINE;

EID: 0032211668     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199811000-00006     Document Type: Article

References (27)

1. RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery. The randomized intervention treatment of angina (RITA) trial. Lancet 341: 573-580, 1991.
2. Hogg PJ, Jackson CM: Fibrin monomer products protect thrombin from inactivation by heparin-antithrombin: III. implications for heparin efficacy. Proc Natl Acad Sci U S A 86: 619-623, 1989.
3. Bar-Shavit R, Eldor A, Vlodavsky I: Binding of thrombin to subendothelial extracellular matrix. J Clin Invest 84: 1098-1104, 1989.
4. Okwusidi JI, Falcone M, Van Ryn-McKenna J, Ofosu FA, Buchanan MR: In vivo catalysis of thrombin inhibition by antithrombin III and heparin co-factor II and antithrombotic effect: differential effects of dermatan sulfate and unfractionated heparin. Thrombotic Haemorrhagic Disorders 2: 17-23, 1990.
5. Brister SJ, Ofosu FA, Buchanan MR: Thrombin generation during cardiac surgery. Is heparin the ideal anticoagulant? Thromb Haemost 70: 259-263, 1993.
6. Boisclair MD, Lane DA, Philippou H, et al: Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82: 3350-3357, 1993.
7. Wagner WR, Johnson PC, Thompson KA, Marrone GC: Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss. Ann Thorac Surg 58: 734-741, 1994.
8. Buchanan MR, Brister SJ, Ofosu FA: Heparin cofactor II and the prevention and treatment of thrombosis, in Buchanan MR, Brister SJ, Ofosu FA (eds): Thrombin: Key Role in Thrombogenesis: Implications for Its Inhibition Clinically, CRC Press, Boca Raton, FL 1994, pp. 77-93.
9. Moen O, Fosse E, Braten J, et al: Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and compliment activation. Perfusion 9: 109-117, 1994.
10. Parault BG, Conrad SA: The effect of extracorporeal circulation time and patient age on platelet retention during cardiopulmonary bypass: a comparison of roller and centrifugal pumps. Journal of Extracorporeal Technology 23: 34-38, 1991.
11. Stubbes MT, Bode W: The structural basis for thrombin inhibition by hirudin and serpins, in Buchanan MR, Brister SJ, Ofosu FA (eds): Thrombin: Key Role in Thrombogenesis: Implications for its Inhibition Clinically, CRC Press, Boca Raton, FL, 1994, pp. 19-52.
12. Larson ML, Abildgaard U, Teien AN, Assang U: Assay of plasma heparin using thrombin chromogenic substrate H-D-phe-piparg-p-NA (S-2238). Thromb Res 13: 285-288, 1978.
13. Olfert ED, Cross BM, McWilliams AA (eds): Guide to the Care and Use of Experimental Animals, vol. 2. Ottawa, Canada, Canadian Council of Animal Care, 1984.
14. Pelter H, Schwartz A, Stuber W: Determination of thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59: 101-106, 1988.
15. Lui L, Dewar L, Song Y, et al: Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thromb Haemost 73: 405-412, 1995.
16. Walenga JM, Bakhos M, Messmore HL, Fareed J, Pifarre R: Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model. Ann Thorac Surg 51: 271-277, 1991.
17. Minitab, Inc.: Reference Manual, Valley Forge, PA, Minitab, Inc., 1988, pp. 8.1-8.36, pp. 10.1-10.22.
18. Fondevila CG, Gill JB, Brister SJ, Turpie AGG, Holder DA, Buchanan MR: Contrast media induces thrombin generation during PTCA. Thromb Haemost 69: 1014, 1993.
19. Wells J, Nicosia S, Wale C, Smith LJ, Buchanan MR: Thrombin generation in patients undergoing carotid endarterectomy: implications in acute vessel wall closure and antithrombotic activity. Thromb Res 75: 419-426, 1994.
20. Chen LB, Buchanan JM: Mitogenic activity of blood components: 1. thrombin and prothrombin. Proc Natl Acad Sci U S A 72: 131-135, 1975.
21. Buchanan MR: Megakaryocyte platelet system: structures and functions, in Lotspeich CA, Stiene-Martin A, Koepke JA (eds): Clinical Hematology: Principles, Procedures, Correlations, Philadelphia, JB Lippincott, 1992, pp. 653-670.
22. Steinbrueckner BE, Steigerwald U, Keller F, Neukam K, Elert O, Babin-Ebell J: Centrifugal and roller pumps: are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass? Heart Vessels 10: 46-53, 1995.
23. Cushman M, Psaty BM, Macy E, et al: Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. Arterioscler Thromb Vasc Biol 16: 1163-1169, 1996.
24. Oltrona L, Eisenberg PR, Lasala JM, Sewall DJ, Shelton ME, Winters KJ: Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions. Circulation 94: 2064-2071, 1996.
25. Hull RD, Raskob GE, Brant RF, Pineo GF, Valintine KA: The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. Arch Intern Med 157: 2317-2321, 1997.
26. Buchanan MR, Brister SJ: Inhibition of chronic vessel wall hyperplasia following acute anti-thrombin treatment: relative effects of heparin and dermatan sulphate. Thromb Res 1998 (in press).
27. Schwartz D, Cancel QV, Waissbluth AD, et al: Differential inhibition of neointimal thickening after balloon injury in the rabbit aorta by glycosaminoglycans. J Am Coll Cardiol 1998 (in press).